Discover

PFS
Provident Financial Services, Inc.
23.75
3 x 23.75
1 x 23.76
bid
ask
-
0.29
1.21%
12:05 PM
timesize
Ytd20.24%
1y29.70%
23.67
day range
24.00
17.61
52 week range
24.56
Open24.00Prev Close24.04Low23.67High24.00Mkt Cap3.13B
Vol201.03KAvg Vol1.01MEPS2.35P/E10.23Forward P/E10.11
Beta0.78Short Ratio5.97Inst. Own76.00%Dividend0.96Div Yield3.99
Ex Div Date05-15Earning07-2950-d Avg22.88200-d Avg21.221yr Est25.75

PFS News

Provident Strengthens its Commitment to Local Communities with $50,000 in Grants to 6 Non-Profit Organizations
globenewswire.com
Provident Strengthens its Commitment to Local Communities with $50,000 in Grants to 6 Non-Profit Org

Funding is provided through the FHLBNY Small Business Recovery Grant Program Funding is provided thr

Inhibrx Biosciences: The Rare Disease Launch Is Only The Opening Act
seekingalpha.com
Inhibrx Biosciences: The Rare Disease Launch Is Only The Opening Act

Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 a

Anthony Petrazzuoli Joins Provident Bank as Senior Vice President, Deposit & Payments Operations Director
globenewswire.com
Anthony Petrazzuoli Joins Provident Bank as Senior Vice President, Deposit & Payments Operations Dir

ISELIN, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial

Sandfire Resources America Delivers Black Butte Copper PFS Upgrade with New Lowry Reserves, 12-Year Mine Life, High-Grade Production Profile and Stronger Project Economics
globenewswire.com
Sandfire Resources America Delivers Black Butte Copper PFS Upgrade with New Lowry Reserves, 12-Year

WHITE SULPHUR SPRINGS, Mont., July 09, 2026 (GLOBE NEWSWIRE) -- Sandfire Resources America Inc. ("Sa

benzinga.com
Raymond James Maintains Strong Buy on Provident Finl Servs, Raises Price Target to $27

Raymond James analyst Steve Moss maintains Provident Finl Servs (NYSE:PFS) with a Strong Buy and

Provident Financial Services, Inc. Schedules Second Quarter Earnings Conference Call
globenewswire.com
Provident Financial Services, Inc. Schedules Second Quarter Earnings Conference Call

ISELIN, N.J., July 01, 2026 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) annou

Tartisan Nickel Corp. Retains Tetra Tech to Complete PFS Gap Analysis for the Kenbridge Nickel-Copper Project, Northwestern Ontario
newsfilecorp.com
Tartisan Nickel Corp. Retains Tetra Tech to Complete PFS Gap Analysis for the Kenbridge Nickel-Coppe

Toronto, Ontario--(Newsfile Corp. - June 25, 2026) - Tartisan Nickel Corp. (CSE: TN) (OTCQX: TTSRF)

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance
gurufocus.com
FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCE

American Ocean Minerals Announces Successful Completion of MV Anuanua Moana Expedition 7, Advancing Deep-Sea Environmental Baseline Research in the Cook Islands
gurufocus.com
American Ocean Minerals Announces Successful Completion of MV Anuanua Moana Expedition 7, Advancing

Today, American Ocean Minerals Corporation (AOMC) announced the successful completion of Expedition

benzinga.com
Provident Financial Services Appoints Adriano Duarte CFO, Effective July 1

Provident Bank, a leading New Jersey-based financial institution, announced today the appointment of

Provident Bank Appoints Adriano Duarte EVP and Chief Financial Officer
globenewswire.com
Provident Bank Appoints Adriano Duarte EVP and Chief Financial Officer

ISELIN, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
gurufocus.com
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediat

AbbVie Announces European Commission Approval of SKYRIZIÂ (risankizumab) for the Treatment of Pediat

Tunkillia Pre-Feasibility Study Begins
accessnewswire.com
Tunkillia Pre-Feasibility Study Begins

Expanded programs targeting Q1 CY27 completion & ML application HIGHLIGHTS GR Engineering appointed

Provident Bank Announces $1 Million in Grants to Ten New Jersey Non-Profit Organizations
globenewswire.com
Provident Bank Announces $1 Million in Grants to Ten New Jersey Non-Profit Organizations

Funds will be used to support revitalization plans for distressed neighborhoods Funds will be used t

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
gurufocus.com
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 4

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 4

Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
gurufocus.com
Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High

[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced new data from two studies evaluating epcorita

New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myel
gurufocus.com
New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demon

New TALVEYÂ (talquetamab-tgvs) plus DARZALEX FASPROÂ (daratumumab and hyaluronidase-fihj) data demon

Results from Incyte's Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progr
gurufocus.com
Results from Incyte's Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evalu

BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit
gurufocus.com
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Ben

[url="]BeOne Medicines Ltd.[/url] (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company

REGN Investors Have Opportunity to Join Regeneron Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
gurufocus.com
REGN Investors Have Opportunity to Join Regeneron Pharmaceuticals, Inc. Fraud Investigation with the

[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it i

WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility
gurufocus.com
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility

WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility PR Newswir

Provident Bank Names Annamaria Vitelli EVP, Chief Wealth Officer and President of Beacon Trust
globenewswire.com
Provident Bank Names Annamaria Vitelli EVP, Chief Wealth Officer and President of Beacon Trust

Seasoned Wealth Management Executive to Lead Strategic Growth of Provident Bank's Wealth Management

Earnings Scheduled For April 29, 2026
benzinga.com
Earnings Scheduled For April 29, 2026

Earnings Scheduled For January 27, 2026
benzinga.com
Earnings Scheduled For January 27, 2026

Earnings Volatility Watch: These 10 Stocks Could Swing 30% Or More This Week
benzinga.com
Earnings Volatility Watch: These 10 Stocks Could Swing 30% Or More This Week

Options markets are pricing in post-earnings swings of up to 50% this week, with regional banks in f

Earnings Scheduled For October 29, 2025
benzinga.com
Earnings Scheduled For October 29, 2025

benzinga.com
Earnings Scheduled For July 24, 2025

benzinga.com
Earnings Scheduled For April 24, 2025

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  During Monday's session, 402 companies made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 930 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Highs On Monday

    Monday's morning session saw 253 companies set new 52-week highs.

benzinga.com
Earnings Scheduled For July 30, 2020

Companies Reporting Before The Bell • Mastercard Inc. (NYSE:MA) is expected to report quarterly ear

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Wednesday

benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Wednesday

benzinga.com
Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Friday

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

benzinga.com
Stocks Trading Ex Dividend For Thurs., Feb. 14, 2019

Stocks Trading Ex Dividend For Thurs., Feb. 14, 2019